Tilray® Expands Global Leadership Team with Appointment of Chief Corporate Development Officer
March 13 2019 - 8:00AM
Business Wire
Former Goldman Sachs Managing Director
Andrew Pucher joins Tilray to lead the company’s global corporate
development activity, including M&A and corporate
investments
Today, Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis
production, research, cultivation and distribution, announces the
expansion of its global senior leadership team with the appointment
of Andrew Pucher as Chief Corporate Development Officer. In his new
role, Andrew will lead Tilray’s corporate development function,
including the team that is responsible for M&A and corporate
investments. He will be based in Toronto, ON, and report to CEO
Brendan Kennedy.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190313005090/en/
Andrew Pucher, Chief Corporate
Development Officer, Tilray (Photo: Business Wire)
Andrew joins Tilray from Goldman Sachs, where he was a Managing
Director and most recently served as Head of Canadian Diversified
Investment Banking, which included coverage of the Canadian
cannabis industry. Previously, he was a member of Goldman Sachs’
Global Healthcare Investment Banking Group in New York, where he
advised on more than $200 billion in announced M&A and
financing transactions, with a focus on the biopharmaceutical
sector. Andrew is a graduate of Simon Fraser University and earned
a JD/MBA from York University.
Brendan Kennedy, Tilray’s CEO, said, “We’re pleased to welcome
Andrew to our senior leadership team to execute strategic
transactions that will further accelerate Tilray’s long-term global
growth. Andrew shares our commitment to a disciplined, strategic
approach in pursuing inorganic growth opportunities. His
transaction experience and industry knowledge will be valuable as
we work to capitalize on the many strategic opportunities available
to us and continue to pursue the disruptive potential of cannabis
across industries including pharmaceuticals, alcohol, consumer
goods, functional food and beverage, retail and
nutraceuticals.”
Recent Tilray transactions and partnerships include: forming a
global partnership with Sandoz, a division of Novartis, to
distribute its medical products; establishing a 50/50 joint venture
with AB InBev, the world’s largest brewer, to develop THC and CBD
beverages; signing an agreement to produce THC and CBD products for
Authentic Brands Group portfolio of brands, which includes Muhammed
Ali, Nine West, Spyder ski gear, Prince tennis wear, Marilyn
Monroe, Juicy Couture and Elvis Presley; acquiring Natura Naturals
Holdings, thereby increasing its cannabis supply; and most
recently, announcing the acquisition of Manitoba Harvest, the
world’s largest hemp company, accelerating the company’s entry into
the natural foods space with hemp and CBD-infused food and wellness
products for North America.
Over the past several months, Tilray has announced appointments
to its senior leadership team, with executives from world-leading
brands: Sascha Mielcarek joined Tilray from Grünenthal to become
Managing Director, Europe; Greg Christopher joined from Nestle to
become Tilray’s EVP of Operations; Rita Seguin came on board from
Diageo to be Tilray’s EVP of Human Resources; Dara Redler, Tilray’s
General Counsel worked previously at The Coca-Cola Company; and
Charlie Cain as VP of Retail came from Starbucks Corporation.
About Tilray®
Tilray (NASDAQ:TLRY) is a global pioneer in the research,
cultivation, production and distribution of cannabis and
cannabinoids currently serving tens of thousands of patients and
consumers in twelve countries spanning five continents.
Cautionary Note Regarding Forward-looking Statements
This press release contains “forward-looking statements” within
the meaning of the U.S. Private Securities Litigation Reform Act of
1995 and “forward-looking information” within the meaning of
Canadian securities laws, or collectively, forward-looking
statements. Forward-looking statements in this press release may be
identified by the use of words such as, “may”, “would”, “could”,
“will”, “likely”, “expect”, “anticipate”, “believe, “intend”,
“plan”, “forecast”, “project”, “estimate”, “outlook” and other
similar expressions and include statements relating to the growth
and global success of the Tilray. Forward-looking statements are
not a guarantee of future performance and are based upon a number
of estimates and assumptions of management in light of management’s
experience and perception of trends, current conditions and
expected developments, as well as other factors that management
believes to be relevant and reasonable in the circumstances,
including assumptions in respect of current and future market
conditions, the current and future regulatory environment and
future approvals and permits. Actual results, performance or
achievement could differ materially from that expressed in, or
implied by, any forward-looking statements in this press release,
and, accordingly, you should not place undue reliance on any such
forward-looking statements and they are not guarantees of future
results. Forward-looking statements involve significant risks,
assumptions, uncertainties and other factors that may cause actual
future results or anticipated events to differ materially from
those expressed or implied in any forward-looking statements.
Please see the heading “Risk Factors” in Tilray’s Quarterly Report
on Form 10-Q, which was filed with the Securities and Exchange
Commission and Canadian securities regulators on November 14, 2018,
for a discussion of the material risk factors that could cause
actual results to differ materially from the forward-looking
information. Tilray does not undertake to update any
forward-looking statements that are included herein, except in
accordance with applicable securities laws.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190313005090/en/
Media: Chrissy Roebuck, 1-833-206-8161,
news@tilray.comInvestors: Katie Turner, +1-646-277-1228,
Katie.turner@icrinc.com
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tilray Brands (NASDAQ:TLRY)
Historical Stock Chart
From Apr 2023 to Apr 2024